Evidence map›Paper›PMID 40967192›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2025

Case - Genetic mosaicism of TSC2 gene in a patient with multifocal renal epithelioid angiomyolipomas.

Nityam Rathi, Ruben Blachman-Braun, Braden Millan, Cathy D Vocke, Christopher J Ricketts, Rabindra Gautam, Krista Reynolds, Maria J Merino, W Marston Linehan, Sandeep Gurram

Abstract read
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nityam RathiUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Ruben Blachman-BraunUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Braden MillanUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Cathy D VockeUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Christopher J RickettsUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Rabindra GautamUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Krista ReynoldsUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Maria J MerinoUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
W Marston LinehanUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Sandeep GurramUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40967192
PMCPMC12604915

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.